Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Anesthesiology. 2013 Nov;119(5):1054–1065. doi: 10.1097/ALN.0b013e3182a8a998

Table 2.

Characteristics of Rare Exome Variants

Family code:
Gene
Codon AA
change
Base Seen
Before?
Poly-
Phen2
Grantham
Score
Phast-
Cons
GERP++
A: RYR1 4234 VAL/LEU G > T G > C 0.994 32 1.0 3.07
B: RYR1 1056 ASP/HIS G > C G > A 1.0 81 0.999 2.94
G: RYR1 2627 VAL/MET G > A No 1.0 21 1.0 4.08
C: CACNA1S 1009 THR/LYS C > A No 0.998 78 0.987 5.12

Each row lists the characteristics of a novel rare variant suspected of being pathogenic. The letter to the left of the gene name indicates which family the variant was found in. All four variants have not been seen in any databases or in 5,379 UW ESP individuals. However, a different base change has been seen at the same position as the first two variants (Families A and B). The table includes scores that assess predicted protein change (PolyPhen2 and Grantham) and evolutionary conservation (PhastCons and GERP++), and highlights in bold either maximal scores (e.g., 1.0 for PhastCons and PolyPhen2) or extreme values.

Adenine = A; amino acid = AA; aspartic acid = ASP; calcium channel, voltage-dependent, L type, α1S subunit gene = CACNA1S; cytosine = C; exome sequencing project = ESP; genomic evolutionary rate profiling = GERP; guanine = G; histidine = HIS; leucine = LEU; lysine = LYS; methionine = MET; ryanodine receptor 1 gene = RYR1; threonine = THR; thymine = T; University of Washington = UW; valine = VAL.